
Helena Kosanovic
Examiner (ID: 5543, Phone: (571)272-9059 , Office: P/3749 )
| Most Active Art Unit | 3749 |
| Art Unit(s) | 3761, 3762, 3743, 3749 |
| Total Applications | 891 |
| Issued Applications | 401 |
| Pending Applications | 37 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20393218
[patent_doc_number] => 20250368693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-04
[patent_title] => PEPTIDE COMPOSITION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/008184
[patent_app_country] => US
[patent_app_date] => 2025-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19008184
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/008184 | PEPTIDE COMPOSITION AND USES THEREOF | Jan 1, 2025 | Pending |
Array
(
[id] => 20039285
[patent_doc_number] => 20250177507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => Multivalent Vaccine Compositions
[patent_app_type] => utility
[patent_app_number] => 18/967715
[patent_app_country] => US
[patent_app_date] => 2024-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18967715
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/967715 | Multivalent Vaccine Compositions | Dec 3, 2024 | Pending |
Array
(
[id] => 20356233
[patent_doc_number] => 12472212
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 18/938752
[patent_app_country] => US
[patent_app_date] => 2024-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 0
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18938752
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/938752 | None | Nov 5, 2024 | Issued |
Array
(
[id] => 19798986
[patent_doc_number] => 20250064911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => BACILLUS CALMETTE-GUERIN (BCG) AND ANTIGEN PRESENTING CELLS FOR TREATMENT OF BLADDER CANCER
[patent_app_type] => utility
[patent_app_number] => 18/933925
[patent_app_country] => US
[patent_app_date] => 2024-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18933925
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/933925 | BACILLUS CALMETTE-GUERIN (BCG) AND ANTIGEN PRESENTING CELLS FOR TREATMENT OF BLADDER CANCER | Oct 30, 2024 | Pending |
Array
(
[id] => 19996773
[patent_doc_number] => 20250134995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-01
[patent_title] => SAPONIN-BASED ADJUVANTS AND METHODS OF CHARACTERIZING SAME
[patent_app_type] => utility
[patent_app_number] => 18/927547
[patent_app_country] => US
[patent_app_date] => 2024-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18927547
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/927547 | SAPONIN-BASED ADJUVANTS AND METHODS OF CHARACTERIZING SAME | Oct 24, 2024 | Pending |
Array
(
[id] => 19754761
[patent_doc_number] => 20250043326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => NEUROTRANSMITTER TRANSPORT IN PROBIOTICS
[patent_app_type] => utility
[patent_app_number] => 18/919141
[patent_app_country] => US
[patent_app_date] => 2024-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18919141
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/919141 | NEUROTRANSMITTER TRANSPORT IN PROBIOTICS | Oct 16, 2024 | Pending |
Array
(
[id] => 19860643
[patent_doc_number] => 20250099429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF VAGINAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/907677
[patent_app_country] => US
[patent_app_date] => 2024-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18907677
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/907677 | COMPOSITIONS AND METHODS FOR TREATMENT OF VAGINAL INFECTIONS | Oct 6, 2024 | Pending |
Array
(
[id] => 19909264
[patent_doc_number] => 12285450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-29
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 18/895456
[patent_app_country] => US
[patent_app_date] => 2024-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 3505
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18895456
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/895456 | None | Sep 24, 2024 | Issued |
Array
(
[id] => 19768480
[patent_doc_number] => 20250049906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => IMMUNOGENIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/894961
[patent_app_country] => US
[patent_app_date] => 2024-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17415
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18894961
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/894961 | IMMUNOGENIC COMPOSITIONS | Sep 23, 2024 | Pending |
Array
(
[id] => 19960315
[patent_doc_number] => 12329787
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => Microbial compositions for the treatment of skin diseases
[patent_app_type] => utility
[patent_app_number] => 18/825396
[patent_app_country] => US
[patent_app_date] => 2024-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 27
[patent_no_of_words] => 28634
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18825396
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/825396 | Microbial compositions for the treatment of skin diseases | Sep 4, 2024 | Issued |
Array
(
[id] => 19815127
[patent_doc_number] => 20250073334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-06
[patent_title] => INJECTABLE HYDROGEL FOR SUSTAINED CO-DELIVERY OF AN ANTIGEN AND AN ADJUVANT, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/826093
[patent_app_country] => US
[patent_app_date] => 2024-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18826093
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/826093 | INJECTABLE HYDROGEL FOR SUSTAINED CO-DELIVERY OF AN ANTIGEN AND AN ADJUVANT, AND USES THEREOF | Sep 4, 2024 | Pending |
Array
(
[id] => 19798987
[patent_doc_number] => 20250064912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => VACCINES FOR NEISSERIA GONORRHOEAE
[patent_app_type] => utility
[patent_app_number] => 18/824050
[patent_app_country] => US
[patent_app_date] => 2024-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18824050
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/824050 | VACCINES FOR NEISSERIA GONORRHOEAE | Sep 3, 2024 | Pending |
Array
(
[id] => 19641388
[patent_doc_number] => 20240415908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => ENTERIC AEROBIZATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/821883
[patent_app_country] => US
[patent_app_date] => 2024-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18821883
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/821883 | Enteric aerobization therapy | Aug 29, 2024 | Issued |
Array
(
[id] => 19743998
[patent_doc_number] => 20250032563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => METHODS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATORY CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/813998
[patent_app_country] => US
[patent_app_date] => 2024-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10005
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18813998
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/813998 | METHODS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATORY CONDITIONS | Aug 22, 2024 | Pending |
Array
(
[id] => 20098987
[patent_doc_number] => 20250228923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-17
[patent_title] => COMBINED VACCINE AGAINST MYCOBACTERIUM TUBERCULOSIS
[patent_app_type] => utility
[patent_app_number] => 18/787546
[patent_app_country] => US
[patent_app_date] => 2024-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18787546
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/787546 | COMBINED VACCINE AGAINST MYCOBACTERIUM TUBERCULOSIS | Jul 28, 2024 | Pending |
| 18/730619 | CHIMERIC POLYPEPTIDES | Jul 18, 2024 | Pending |
Array
(
[id] => 19770054
[patent_doc_number] => 20250051480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => SUBSTANCES AND METHODS FOR THE USE IN PREVENTION AND/OR TREATMENT IN HUNTINGTON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/768852
[patent_app_country] => US
[patent_app_date] => 2024-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18768852
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/768852 | SUBSTANCES AND METHODS FOR THE USE IN PREVENTION AND/OR TREATMENT IN HUNTINGTON'S DISEASE | Jul 9, 2024 | Pending |
Array
(
[id] => 19657013
[patent_doc_number] => 20240424078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => GROUP B STREPTOCOCCUS CAPSULAR POLYSACCHARIDE VACCINE AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/761709
[patent_app_country] => US
[patent_app_date] => 2024-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18761709
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/761709 | GROUP B STREPTOCOCCUS CAPSULAR POLYSACCHARIDE VACCINE AND METHODS OF USE | Jul 1, 2024 | Abandoned |
Array
(
[id] => 19657010
[patent_doc_number] => 20240424075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => IMMUNOREACTIVE PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 18/754918
[patent_app_country] => US
[patent_app_date] => 2024-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15113
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18754918
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/754918 | Immunoreactive peptides | Jun 25, 2024 | Issued |
Array
(
[id] => 19641383
[patent_doc_number] => 20240415903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => GABA-PRODUCING GASTROINTESTINAL BACTERIA FOR SUPPORT OF MENTAL HEALTH
[patent_app_type] => utility
[patent_app_number] => 18/745165
[patent_app_country] => US
[patent_app_date] => 2024-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18745165
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/745165 | GABA-PRODUCING GASTROINTESTINAL BACTERIA FOR SUPPORT OF MENTAL HEALTH | Jun 16, 2024 | Pending |